These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28110418)

  • 41. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated?
    Nester CM; Thomas CP
    Hematology Am Soc Hematol Educ Program; 2012; 2012():617-25. PubMed ID: 23233643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
    Sperati CJ; Moliterno AR
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
    Mohlin FC; Nilsson SC; Levart TK; Golubovic E; Rusai K; Müller-Sacherer T; Arbeiter K; Pállinger É; Szarvas N; Csuka D; Szilágyi Á; Villoutreix BO; Prohászka Z; Blom AM
    Mol Immunol; 2015 Jun; 65(2):367-76. PubMed ID: 25733390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society.
    Sawai T; Nangaku M; Ashida A; Fujimaru R; Hataya H; Hidaka Y; Kaname S; Okada H; Sato W; Yasuda T; Yoshida Y; Fujimura Y; Hattori M; Kagami S;
    Clin Exp Nephrol; 2014 Feb; 18(1):4-9. PubMed ID: 24343712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
    Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome.
    Siomou E; Gkoutsias A; Serbis A; Kollios K; Chaliasos N; Frémeaux-Bacchi V
    Pediatr Nephrol; 2016 Mar; 31(3):513-7. PubMed ID: 26572892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase.
    Sakurai S; Kato H; Yoshida Y; Sugawara Y; Fujisawa M; Yasumoto A; Matsumoto M; Fujimura Y; Yatomi Y; Nangaku M
    J Atheroscler Thromb; 2020 Apr; 27(4):353-362. PubMed ID: 31484852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C3:CH50 ratio as a proposed composite marker for eculizumab monitoring in atypical hemolytic uremic syndrome: Preliminary results.
    Kerboua KE; Haiba F; Batouche D
    J Immunoassay Immunochem; 2017; 38(2):178-189. PubMed ID: 27617501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.
    Mahmood U; Isbel N; Mollee P; Mallett A; Govindarajulu S; Francis R
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():15-17. PubMed ID: 28176474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.
    Cugno M; Gualtierotti R; Possenti I; Testa S; Tel F; Griffini S; Grovetti E; Tedeschi S; Salardi S; Cresseri D; Messa P; Ardissino G
    J Thromb Haemost; 2014 Sep; 12(9):1440-8. PubMed ID: 24853860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical hemolytic-uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes.
    Marini SC; Gomes M; Guilherme R; Carda JP; Pinto CS; Fidalgo T; Ribeiro ML
    Blood Coagul Fibrinolysis; 2019 Mar; 30(2):68-70. PubMed ID: 30676336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemolytic uremic syndrome and IgA nephropathy in a child: Coincidence or not?
    Sürmeli-Döven S; Delibaş A; Gürses İ; Kayacan UR; Coşkun-Yılmaz B; Esen K; Korkmaz E; Özaltın F
    Turk J Pediatr; 2018; 60(1):81-85. PubMed ID: 30102484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M; Basturk T; Sahutoglu T; Sakaci T; Koc Y; Ahbap E; Akgol C; Kara E; Brocklebank V; Goodship TH; Kavanagh D; Unsal A
    J Med Case Rep; 2015 Apr; 9():92. PubMed ID: 25925370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report.
    Tawhari M; Alhamadh MS; Alhabeeb AY; Almudayfir Z; Radwi M
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients.
    Raina R; Chauvin A; Fox K; Kesav N; Ascha M; Vachharajani TJ; Krishnappa V
    Ann Transplant; 2018 Sep; 23():631-638. PubMed ID: 30190449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report.
    Zhu Z; Chen H; Gill R; Wang J; Spitalewitz S; Gotlieb V
    J Med Case Rep; 2016 Feb; 10():38. PubMed ID: 26911616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F; Payzin BK; Ecemis S; Güler N; Yilmaz AF; Topcugil F; Berdeli A
    Transfus Apher Sci; 2016 Dec; 55(3):357-362. PubMed ID: 27742267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.